Guidant Gains FDA Approval Of MADIT II Indication, Reports Upbeat ICD Sales
This article was originally published in The Gray Sheet
Executive Summary
Patient electrophysiology testing "may not be required" for some patients prior to Guidant ICD implantation under an expanded indication, FDA says
You may also be interested in...
Patient-Reported Outcomes In Device Trials: FDA Guidance Under Review
FDA is reviewing a draft guidance on use of patient-reported outcome data in device evaluations, according to Division of Cardiovascular Devices Medical Officer Neal Muni, MD
Patient-Reported Outcomes In Device Trials: FDA Guidance Under Review
FDA is reviewing a draft guidance on use of patient-reported outcome data in device evaluations, according to Division of Cardiovascular Devices Medical Officer Neal Muni, MD
Simple Back-Up Superior To Dual-Chamber Pacing For Certain ICD Patients
ICD dual-chamber pacing is inappropriate for patients without demonstrated bradycardia, according to the St. Jude-sponsored DAVID trial investigators